Back to results
US 7,678,795 B2Granted
Pyridazines as 11b-HSD1 inhibitors
AssigneeHoffman-La Roche Inc.
InventorsKurt Amrein, Daniel Hunziker, Bernd Kuhn, Alexander V Mayweg, Werner Neidhart
Life of this patent
Estimating the term…
Abstract
Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
Claims17
A compound of the formula:
- wherein
- R1 and R2 together with the carbon atoms Ca and Cb to which they are attached form
- R3 is hydrogen, alkyl, cycloalkyl or trifluoromethyl;
- R4 is benzyl, cycloalkyl, arylcycloalkyl, adamantyl, aryl or heterocyclyl, wherein benzyl, cycloalkyl, arylcycloalkyl, aryl and heterocyclyl are optionally substituted with one to three substituents independently selected from alkyl, cycloalkyl, alkoxy, hydroxy, halogen, trifluormethyl, trifluoromethoxy, benzyl, phenyl and phenyl substituted with one to three substituents independently selected from alkyl, alkoxy, hydroxy, cycloalkyl, halogen and trifluoromethyl;
- or pharmaceutically acceptable salts and esters thereof.
2 more elements
Dependencies are inferred from the claim text.